Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ana María Jimenez-Gordo"'
Autor:
Silvia Roa, Enrique Casado, Carmen Sandoval, Ramiro López-Menchaca, María Merino, Gerardo Gutiérrez-Gutiérrez, Ana María Jimenez-Gordo, Patricia Martínez-Martin, María Sereno, Sandra Falagan
Publikováno v:
Lung Cancer
Lung Cancer (Amsterdam, Netherlands)
Lung Cancer (Amsterdam, Netherlands)
Autor:
Ana María Jimenez-Gordo, Ana López-Alfonso, X. Mielgo, Luis Enrique Chiara, Miriam Dorta, José Luis López, Berta Hernandez, Ana Pertejo, Raquel Molina, Gonzalo Colmenarejo, Javier Baena-Espinar, Rosa Álvarez-Álvarez, Ana Collazo-Lorduy, Ana Manuela Martín, Carlos Aguado, Ana Ramírez de Molina, Ana Sanchez, María Sereno, Ana Lopez-Martin, Enrique Casado
Publikováno v:
Cancers, Vol 13, Iss 4205, p 4205 (2021)
Cancers
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Volume 13
Issue 16
Cancers
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Volume 13
Issue 16
Simple Summary Infections with COVID-19 in neutropenic cancer patients are related to poor outcomes. A G-CSF treatment used in neutropenic cancer with SARS-CoV-2 infections is related to a higher rate of respiratory failure according to progressive a
Autor:
Cristina Aguayo, Sandra Falagan, María Sereno, María Merino, Ana María Jimenez-Gordo, Enrique Casado, Francisco Zambrana, Cesar Gomez Raposo, Silvia Roa, Inmaculada Toboso del Amo, Juan Moreno-Rubio, Miriam López-Gómez, Ana López-Alfonso
Publikováno v:
Journal of Clinical Oncology. 38:e15012-e15012
e15012 Background: Antinuclear antibodies (ANAs) constitute a spectrum of autoantibodies targeted to nuclear and cytoplasmic components of the cells considered serological markers for different autoimmune disease. However, ANAs are also presented in
Autor:
Ana López-Alfonso, Ana María Jimenez-Gordo, Jaime Feliu, Sergio Martínez-Recio, Ismael Ghanem, Miriam López-Gómez, Laura Gutiérrez Sainz, Patricia Ibeas, Mar Perez, Oliver Higuera, Raquel Molina, Nuria Rodríguez-Salas
Publikováno v:
Journal of Clinical Oncology. 38:124-124
124 Background: Colorectal cancer is currently the third most common cancer worldwide. The results of the VELOUR study showed that the addition of aflibercept to Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) produced an advantage in both progres
Autor:
Bruno Sainz, Marta Muñoz, Ana María Jimenez-Gordo, Miriam López-Gómez, Juan Moreno-Rubio, Enrique Casado, Silvia Salinas, Gabrielle D’errico, Sonia Alcalá
Publikováno v:
Critical reviews in oncology/hematology. 107
Cancer stem cells (CSCs) are a very heterogeneous subpopulation of “stem-like” cancer cells that have been identified in many cancers, including leukemias and solid tumors. It is believed that CSCs drive tumor growth, malignant behavior and are r
Autor:
Jaime Feliu, Ana María Jimenez-Gordo, Juan Carlos Cámara, Javier de Castro, Alberto Alonso-Babarro, Rosario Madero, José Ramón Rodríguez-Aizcorbe, Enrique Espinosa, Beatriz Martínez, Raquel Molina, Manuel González-Barón, Jesús Domingo Acedo, María Luisa García-Paredes
Publikováno v:
JNCI: Journal of the National Cancer Institute. 103:1613-1620
Background Determining life expectancy in terminally ill cancer patients is a difficult task. We aimed to develop and validate a nomogram to predict the length of survival in patients with terminal disease. Methods From February 1, 2003, to December
Autor:
M. Lopez Gomez, Francisco Zambrana, Bruno Sainz, Silvia Salinas, Ana María Jimenez-Gordo, Marielena Muñoz, Sonia Alcalá, Juan Moreno-Rubio, Enrique Casado
Publikováno v:
Annals of Oncology. 29:viii681-viii682
Autor:
Ana María Jimenez-Gordo, A. Pertejo Fernandez, A. Lopez Alfonso, Nuria Rodríguez-Salas, Juan De la camara, G. Reynoso, B. Martínez-Amores, Raquel Molina, J. Miranda Poma, M. Soriano Segura
Publikováno v:
Annals of Oncology. 29:v75